speb/financial-data huggingface dataset:
Stock screener scorecard for HUW.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 153875120 (Micro Cap ($50M-$300M))
P/E ratio: 0.09507722007722007
Debt to equity: 0.3014
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HYMC (quarterly, report date 2026-03-31)
Altman Z-score: 19.737805219829244 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.661401525475984%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -18.80012796627712%
Rule of 40 score: 0
Market cap: 1847311232 (Small Cap ($300M-$2B))
Debt to equity: 0.0001
Free cash flow (dilution adjusted): -51020000
Operating income: -49951000
Net income: -48287000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for JEMI.L (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 516159200 (Small Cap ($300M-$2B))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KALA (quarterly, report date 2026-03-31)
Altman Z-score: -74.05418714677614 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.063655794071181%
Capitalized R&D asset: 2328130
ROCI (R&D adjusted): -29.991807451424705%
Rule of 40 score: 0
Market cap: 11789643 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -2424000
Operating income: -1802000
Net income: -1621000
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for KURN.SW (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 780900480 (Small Cap ($300M-$2B))
P/E ratio: 579.746835443038
Debt to equity: 0.0165
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MRNA (quarterly, report date 2026-03-31)
Altman Z-score: 3.8592996732754377 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.591160220994478%
Capitalized R&D asset: 1432580000
ROCI (R&D adjusted): -14.06731663876638%
Rosenberg metric: -1.0193548387096774
Free cash flow margin: -204.62724935732646%
Revenue growth: -63.0579297245964%
Rule of 40 score: -267.68517908192285
Market cap: 21454233600 (Large Cap ($10B-$200B))
Debt to equity: 0.1752
Free cash flow (dilution adjusted): -796000000
Operating income: -1388000000
Net income: -1343000000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for MTB (quarterly, report date 2026-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 36175273984 (Large Cap ($10B-$200B))
P/E ratio: 12.599788247750132
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MTU.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 725529664 (Small Cap ($300M-$2B))
P/E ratio: 12.218205718041407
Debt to equity: 0.36060000000000003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NAS.L (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 526536320 (Small Cap ($300M-$2B))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NAS.L (annual, report date 2026-01-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.042604562606495%
Capitalized R&D asset: 0
Free cash flow margin: 33.00075776711291%
Revenue growth: -18.680274728801592%
Rule of 40 score: 14.320483038311316
Market cap: 526536320 (Small Cap ($300M-$2B))
P/E ratio: 0.15096440394525784
Debt to equity: 0
Free cash flow (dilution adjusted): 14516666.666666668
Net income: 40695833.333333336
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for NRA.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.7499151991023315 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.7100015458339777%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3224136708501737%
Free cash flow margin: -5.138455538221528%
Revenue growth: 32.2842770540436%
Rule of 40 score: 27.14582151582207
Market cap: 26499899392 (Large Cap ($10B-$200B))
P/E ratio: 178.30459770114942
Debt to equity: 4.7924
Free cash flow (dilution adjusted): -527000000
Operating income: 373000000
Net income: 125000000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OUT (quarterly, report date 2026-03-31)
Altman Z-score: 0.32117045639926195 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.6066937015553617%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.198929602393645%
Free cash flow margin: 10.195530726256983%
Revenue growth: -17.46397694524496%
Rule of 40 score: -7.268446218987975
Market cap: 5639313920 (Mid Cap ($2B-$10B))
P/E ratio: 24.53271028037383
Debt to equity: 6.0402
Free cash flow (dilution adjusted): 43800000
Operating income: 56900000
Net income: 19300000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for OVT.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6981781 (Nano Cap (< $50M))
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for OVT.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6981781 (Nano Cap (< $50M))
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for RELCHEMQ.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.39091311389054406 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.826782349251746%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.5429669952441474%
Revenue growth: 2.375220950963884%
Rule of 40 score: 2.375220950963884
Market cap: 960220160 (Small Cap ($300M-$2B))
P/E ratio: 0.16448889934222577
Debt to equity: 1.8746
Operating income: 558753.7091988131
Net income: 185025.43450614667
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for RELCHEMQ.NS (annual, report date 2026-03-31)
Altman Z-score: 1.0588446309022979 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.538458512931411%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.584283884388097%
Free cash flow margin: 5.764852386342981%
Revenue growth: -8.485645307562956%
Rule of 40 score: -2.7207929212199753
Market cap: 960220160 (Small Cap ($300M-$2B))
P/E ratio: 0.16448889934222577
Debt to equity: 1.8746
Free cash flow (dilution adjusted): 2211646.8842729973
Operating income: 2746492.1576939384
Net income: 557598.5587113184
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SMCP.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 403848352 (Small Cap ($300M-$2B))
P/E ratio: 35.182072829131656
Debt to equity: 0.4939
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SMJ.L (quarterly, report date 2026-01-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 43546424 (Nano Cap (< $50M))
P/E ratio: 0.13995726495726496
Debt to equity: 0.0479
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SURG (quarterly, report date 2026-03-31)
Altman Z-score: -20.922079769418335 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -28.83186875261316%
Revenue growth: -1.2542405152478158%
Rule of 40 score: -30.086109267860977
Market cap: 6054377 (Nano Cap (< $50M))
Debt to equity: -0.6498791602200908
Free cash flow (dilution adjusted): -4608481
Operating income: -11199366
Net income: -12050883
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SYZ.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.761660330294852 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 35.33806499813223%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8860362088812919%
Free cash flow margin: -3.9385951310280656%
Revenue growth: -3.5255377976300517%
Rule of 40 score: -7.464132928658117
Market cap: 16740032 (Nano Cap (< $50M))
P/E ratio: 36.79310364754099
Debt to equity: 0.7595999999999999
Free cash flow (dilution adjusted): -583908.0459770114
Operating income: 291954.0229885057
Net income: 140229.88505747126
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for THEON.AS (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 4378949.516666667
Rule of 40 score: 0
Market cap: 2490954240 (Mid Cap ($2B-$10B))
P/E ratio: 26.926977687626778
Debt to equity: 0.8364
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for THEON.AS (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2490954240 (Mid Cap ($2B-$10B))
P/E ratio: 26.926977687626778
Debt to equity: 0.8364
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for UIS (quarterly, report date 2026-03-31)
Altman Z-score: -1.5351090513350596 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 11811000
ROCI (R&D adjusted): -1.3137025304538141%
Rosenberg metric: -10.135802469135802
Free cash flow margin: -6.764168190127971%
Revenue growth: -23.82941688424717%
Rule of 40 score: -30.59358507437514
Market cap: 227464112 (Micro Cap ($50M-$300M))
Debt to equity: -2.6899824253075573
Free cash flow (dilution adjusted): -29600000
Operating income: -13900000
Net income: -35800000
Long score: 1 | Short score: 17
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for VRV.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.38848888881689697 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8226715221627532%
Free cash flow margin: 25.684943987288722%
Revenue growth: -31.95711844813014%
Rule of 40 score: -6.272174460841416
Market cap: 264153824 (Micro Cap ($50M-$300M))
Debt to equity: 1.2052
Free cash flow (dilution adjusted): 3686192.4686192465
Operating income: 878347.280334728
Net income: -305334.7280334728
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for WA1.AX (annual, report date 2025-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -26.940131470805635%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.586629475592421%
Rule of 40 score: 0
Market cap: 832657024 (Small Cap ($300M-$2B))
Debt to equity: 0.0054
Free cash flow (dilution adjusted): -20460335.29411765
Operating income: -5422745.098039215
Net income: -3138549.019607843
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for WA1.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 832657024 (Small Cap ($300M-$2B))
Debt to equity: 0.0054
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for WCE.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 34430504 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for YMAT (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7298387 (Nano Cap (< $50M))
Debt to equity: -1.877489714332507
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for YMAT (annual, report date 2025-12-31)
Altman Z-score: -4.2895203897846095 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 49929.460444693126
Rosenberg metric: -0.005232046123255145
Free cash flow margin: -36.6018540839946%
Revenue growth: -40.73384008298728%
Rule of 40 score: -77.33569416698188
Market cap: 7298387 (Nano Cap (< $50M))
Debt to equity: -1.877489714332507
Free cash flow (dilution adjusted): -116302.49679897568
Operating income: -660119.0140845071
Net income: -645762.3559539053
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for YOU.L (quarterly, report date 2026-01-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 282353056 (Micro Cap ($50M-$300M))
P/E ratio: 0.3333333333333333
Debt to equity: 1.1239
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1310.HK (annual, report date 2025-08-31)
Altman Z-score: 0.7736162512290917 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -12.175742562772069%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.339595298472974%
Free cash flow margin: 12.582933146139%
Revenue growth: 4.618432812749393%
Rule of 40 score: 17.201365958888395
Market cap: 7098823526.4 (Mid Cap ($2B-$10B))
P/E ratio: 34.31637948797277
Debt to equity: 4.933782813613558
Free cash flow (dilution adjusted): 179755712.45186135
Operating income: 131595121.95121951
Net income: 26555070.603337612
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 2768.T (quarterly, report date 2025-09-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 804346327489.1299 (Mega Cap (>= $200B))
Debt to equity: 1.2384513510293136
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4059.T (annual, report date 2025-09-30)
Altman Z-score: 9.274512226549097 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.8206961272467527%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.3936185943730917%
Free cash flow margin: 18.70968182967873%
Revenue growth: -7.31311439178723%
Rule of 40 score: 11.396567437891498
Market cap: 1980348512.9999998 (Small Cap ($300M-$2B))
P/E ratio: 138.80623207401695
Debt to equity: 0
Free cash flow (dilution adjusted): 552543.7415881561
Operating income: 136164.19919246298
Net income: 96009.42126514133
Long score: 8 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 6049.T (annual, report date 2025-10-31)
Altman Z-score: 7.367560259723234 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.720950524904219%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.8119130807104447%
Free cash flow margin: 18.132467049739727%
Revenue growth: -7.517923032385925%
Rule of 40 score: 10.614544017353802
Market cap: 5619524484 (Mid Cap ($2B-$10B))
P/E ratio: 33.11621997630988
Debt to equity: 0.001024566260258277
Free cash flow (dilution adjusted): 4323541.2605588045
Operating income: 1692813.5152696555
Net income: 1102605.5880441845
Long score: 8 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 9720.T (annual, report date 2025-11-30)
Altman Z-score: 2.2632990579675263 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.2378405128301917%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.923556535471071%
Free cash flow margin: 2.715744102397757%
Revenue growth: 7.851035448979108%
Rule of 40 score: 10.566779551376865
Market cap: 7674218500 (Mid Cap ($2B-$10B))
P/E ratio: 38.10984948180225
Debt to equity: 0.6495195838013991
Free cash flow (dilution adjusted): 1134662.1448681853
Operating income: 1942743.7931917072
Net income: 1288527.0028154594
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for DBL (annual, report date 2025-09-30)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.832999322908638%
Capitalized R&D asset: 0
Free cash flow margin: 157.18911507895842%
Revenue growth: -54.15895036814155%
Rule of 40 score: 103.03016471081688
Market cap: 288274345.74 (Micro Cap ($50M-$300M))
P/E ratio: 14.02070500802578
Debt to equity: 0.04985015276712249
Free cash flow (dilution adjusted): 33363036
Net income: 20560617
Long score: 4 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for FISI (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.579508575911458%
Capitalized R&D asset: 0
Free cash flow margin: 4.1787968251491545%
Revenue growth: 112.64952936451111%
Rule of 40 score: 116.82832618966026
Market cap: 602009194.6 (Small Cap ($300M-$2B))
P/E ratio: 8.041048721065355
Debt to equity: 0.5314874358754178
Free cash flow (dilution adjusted): 10177000
Net income: 74867000
Long score: 4 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for GOS.DE (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.312952166591923%
Capitalized R&D asset: 0
Free cash flow margin: -86.92586174356158%
Revenue growth: 8.915757213335326%
Rule of 40 score: -78.01010453022626
Market cap: 260866385701.44705 (Mega Cap (>= $200B))
P/E ratio: 15.187842670088907
Debt to equity: 3.089892135838428
Free cash flow (dilution adjusted): -50663000000
Net income: 17176000000
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HYMC (annual, report date 2025-12-31)
Altman Z-score: 22.27223017634077 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.345773181403402%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -17.485399129627528%
Rule of 40 score: 0
Market cap: 2171641485.77 (Mid Cap ($2B-$10B))
Debt to equity: 0.00018250310021292028
Free cash flow (dilution adjusted): -85334000
Operating income: -44639000
Net income: -40664000
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for JEMI.L (annual, report date 2025-07-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 11.946245122596892%
Capitalized R&D asset: 0
Free cash flow margin: 27.15379138483446%
Revenue growth: 99.4578909637115%
Rule of 40 score: 126.61168234854597
Market cap: 3777405.7465999997 (Nano Cap (< $50M))
P/E ratio: 0.07034144143684475
Debt to equity: 0.06724031304363302
Free cash flow (dilution adjusted): 20340000
Net income: 71601333.33333333
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for KALA (annual, report date 2025-12-31)
Altman Z-score: 9.127089163556292 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -381.3321898227559%
Capitalized R&D asset: 39716360
ROCI (R&D adjusted): -85.78457607365588%
Rule of 40 score: 0
Market cap: 516796078.6 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -39001000
Operating income: -39032000
Net income: -26980000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for MRNA (annual, report date 2025-12-31)
Altman Z-score: 2.6120833330002853 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -32.725359522974394%
Capitalized R&D asset: 7774660000
ROCI (R&D adjusted): -22.704460600790995%
Rosenberg metric: -0.149900946511116
Free cash flow margin: -77.42130750605327%
Revenue growth: -26.85410670799203%
Rule of 40 score: -104.2754142140453
Market cap: 11701226777.91 (Large Cap ($10B-$200B))
Debt to equity: 0.1508670520231214
Free cash flow (dilution adjusted): -2558000000
Operating income: -3074000000
Net income: -2822000000
Long score: 3 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MTB (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.526927547462224%
Capitalized R&D asset: 0
Free cash flow margin: 29.69269102990033%
Revenue growth: 4.3440580652150365%
Rule of 40 score: 34.03674909511537
Market cap: 28798187100 (Large Cap ($10B-$200B))
P/E ratio: 10.101082813048054
Debt to equity: 0.4459334407238578
Free cash flow (dilution adjusted): 2860000000
Net income: 2851000000
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for NRA.DE (annual, report date 2025-12-31)
Altman Z-score: 2.3255612558860452 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -19.87599645704163%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.208469518260623%
Free cash flow margin: 2.0545046071696027%
Revenue growth: 9.182367579097049%
Rule of 40 score: 11.236872186266652
Market cap: 34115271102.117645 (Large Cap ($10B-$200B))
P/E ratio: 39.485267479302834
Debt to equity: 9.888161808447352
Free cash flow (dilution adjusted): 631000000
Operating income: 1944000000
Net income: 864000000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for OUT (annual, report date 2025-12-31)
Altman Z-score: 0.5702895094356919 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.419287211740041%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.531271636279714%
Free cash flow margin: 9.237320521919528%
Revenue growth: 0.043694357966027636%
Rule of 40 score: 9.281014879885555
Market cap: 4158620106.2000003 (Mid Cap ($2B-$10B))
P/E ratio: 28.289932695238093
Debt to equity: 5.628832265976291
Free cash flow (dilution adjusted): 169200000
Operating income: 311300000
Net income: 147000000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SCANA.OL (annual, report date 2025-12-31)
Altman Z-score: 1.4617543674475229 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.1832493054841031%
Free cash flow margin: 8.626302083333332%
Revenue growth: -0.05022506515044314%
Rule of 40 score: 8.57607701818289
Market cap: 656529163.3891435 (Small Cap ($300M-$2B))
Debt to equity: 0.7502387774594078
Free cash flow (dilution adjusted): 13184079.60199005
Operating income: -1144278.606965174
Net income: -3611940.2985074623
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SMJ.L (annual, report date 2025-07-31)
Altman Z-score: 1.5213606101942403 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.7610162094285733%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.421208771217867%
Free cash flow margin: -9.819277108433734%
Revenue growth: 9.762034514078126%
Rule of 40 score: -0.057242594355608745
Market cap: 452882.79269999993 (Nano Cap (< $50M))
P/E ratio: 0.08859209559859155
Debt to equity: 0.0846228647121429
Free cash flow (dilution adjusted): -3042666.6666666665
Operating income: -802666.6666666666
Net income: 6816000
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for SURG (annual, report date 2025-12-31)
Altman Z-score: -21.66356398884957 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -42.05098158591589%
Revenue growth: -6.435902606541434%
Rule of 40 score: -48.486884192457325
Market cap: 41953564.65 (Nano Cap (< $50M))
Debt to equity: -0.8817936508894898
Free cash flow (dilution adjusted): -23953467
Operating income: -30660012
Net income: -36068870
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SYZ.DE (annual, report date 2025-12-31)
Altman Z-score: 1.4179109260501166 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.246546984762617%
Free cash flow margin: 8.347406938287241%
Revenue growth: -7.531028312461396%
Rule of 40 score: 0.8163786258258448
Market cap: 20790040.04 (Nano Cap (< $50M))
Debt to equity: 0.8148711877783416
Free cash flow (dilution adjusted): 5582352.94117647
Operating income: -1818823.5294117648
Net income: -10927058.823529413
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for VRV.DE (annual, report date 2025-12-31)
Altman Z-score: 3.368518440988732 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -9.081453032485198%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.0258509422133715%
Free cash flow margin: 1.6737366201810415%
Revenue growth: 51.17172920995181%
Rule of 40 score: 52.84546583013285
Market cap: 3786322425.364706 (Mid Cap ($2B-$10B))
P/E ratio: 5447.945935776555
Debt to equity: 1.2451019781154726
Free cash flow (dilution adjusted): 1003373.231773667
Operating income: 7255930.359085963
Net income: 75625.68008705115
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for WK (annual, report date 2025-12-31)
Altman Z-score: 1.962804181021062 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 401131150
ROCI (R&D adjusted): -1.831663609774475%
Rosenberg metric: 0.6609117060149792
Free cash flow margin: 1.6571931157355908%
Revenue growth: 19.749824010396924%
Rule of 40 score: 21.407017126132516
Market cap: 4532416196.25 (Mid Cap ($2B-$10B))
Debt to equity: -146.67917586460632
Free cash flow (dilution adjusted): 14659000
Operating income: -42441000
Net income: -26169000
Long score: 7 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for YOU.L (annual, report date 2024-07-31)
Altman Z-score: 0.739054327718818 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.626506024096386%
Free cash flow margin: 5.457798985982701%
Revenue growth: 29.810298102981037%
Rule of 40 score: 35.268097088963735
Market cap: 5119846.2898 (Nano Cap (< $50M))
Debt to equity: 1.3034934497816597
Free cash flow (dilution adjusted): 23461538.46153846
Operating income: 13974358.974358974
Net income: -2692307.692307692
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0312.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 132235000 (Micro Cap ($50M-$300M))
Debt to equity: 1.0539
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0312.HK (annual, report date 2025-12-31)
Altman Z-score: -0.44417839686448846 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.414550377067698%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.64202574936806%
Free cash flow margin: 37.351276937652784%
Revenue growth: -0.5314375581731343%
Rule of 40 score: 36.81983937947965
Market cap: 132235000 (Micro Cap ($50M-$300M))
Debt to equity: 1.0539
Free cash flow (dilution adjusted): 10193857.142857144
Operating income: 14071000
Net income: -13772285.714285715
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 0321.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1533682688 (Small Cap ($300M-$2B))
P/E ratio: 1.2648809523809523
Debt to equity: 0.1711
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1399.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 430550528 (Small Cap ($300M-$2B))
P/E ratio: 1.2210796915167095
Debt to equity: 1.0431
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1442.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 629520000 (Small Cap ($300M-$2B))
Debt to equity: 0.6922
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1632.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 48617016 (Nano Cap (< $50M))
Debt to equity: 0.8234999999999999
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1689.HK (annual, report date 2025-12-31)
Altman Z-score: 1.7117257249526396 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.300825362945092%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.640430606956752%
Free cash flow margin: 18.539642871538554%
Revenue growth: 3.271480372762798%
Rule of 40 score: 21.811123244301353
Market cap: 203414704 (Micro Cap ($50M-$300M))
Debt to equity: 0.02
Free cash flow (dilution adjusted): 3547172.236503856
Operating income: 1492159.383033419
Net income: -4371465.29562982
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 1689.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 203414704 (Micro Cap ($50M-$300M))
Debt to equity: 0.02
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1888.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 118872702976 (Large Cap ($10B-$200B))
P/E ratio: 2.1537802386131433
Debt to equity: 0.2561
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1897.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6525255168 (Mid Cap ($2B-$10B))
P/E ratio: 0.1878386294434905
Debt to equity: 0.0003
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2078.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 148726224 (Micro Cap ($50M-$300M))
Debt to equity: 0.1423
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2078.HK (annual, report date 2025-12-31)
Altman Z-score: 0.018109616067431222 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -14.944429935289168%
Free cash flow margin: -18.24425550129385%
Revenue growth: -60.87414580448005%
Rule of 40 score: -79.1184013057739
Market cap: 148726224 (Micro Cap ($50M-$300M))
Debt to equity: 0.1423
Free cash flow (dilution adjusted): -8436889.460154241
Operating income: -13239074.550128534
Net income: -7599614.39588689
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for 2190.HK (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 33520109.617941163
Rule of 40 score: 0
Market cap: 6395653120 (Mid Cap ($2B-$10B))
P/E ratio: 3.359631238365393
Debt to equity: 0.0197
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2222.HK (annual, report date 2025-12-31)
Altman Z-score: 2.8820998955277286 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.6555969116094%
Capitalized R&D asset: 1655473.474203288
ROCI (R&D adjusted): 1.2259821141635907%
Rosenberg metric: 0.21485588754273205
Free cash flow margin: 6.468878141571481%
Revenue growth: -6.034582220299026%
Rule of 40 score: 0.4342959212724553
Market cap: 334800640 (Small Cap ($300M-$2B))
P/E ratio: 0.4641530991145388
Debt to equity: 0.039
Free cash flow (dilution adjusted): 1853341.9023136245
Operating income: 809768.6375321336
Net income: 1591002.5706940873
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 2222.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 334800640 (Small Cap ($300M-$2B))
P/E ratio: 0.4641530991145388
Debt to equity: 0.039
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2669.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 37677101056 (Large Cap ($10B-$200B))
P/E ratio: 0.1316838543987065
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2889.HK (annual, report date 2025-12-31)
Altman Z-score: 3.1745669676711565 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -71.05141004392317%
Capitalized R&D asset: 84806619.7470006
ROCI (R&D adjusted): -25.40586992256955%
Rosenberg metric: 0.7323326806588497
Free cash flow margin: -53.152496804593866%
Revenue growth: 43.141905917647684%
Rule of 40 score: -10.010590886946183
Market cap: 21019969536 (Large Cap ($10B-$200B))
Debt to equity: 1.0458
Free cash flow (dilution adjusted): -266501000
Operating income: -133110142.85714285
Net income: -156189714.2857143
Long score: 2 | Short score: 11
Recommendation: Short
Stock screener scorecard for 3132.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 603186003968 (Mega Cap (>= $200B))
P/E ratio: 0.09302451946766253
Debt to equity: 0.268
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3622.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3611425792 (Mid Cap ($2B-$10B))
P/E ratio: 0.13510690384179505
Debt to equity: 0.12960000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3622.T (annual, report date 2026-03-31)
Altman Z-score: 6.27007453405047 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.523516850588463%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.941269636197504%
Free cash flow margin: 2.8883562822531985%
Revenue growth: 1.7699751618162396%
Rule of 40 score: 4.658331444069438
Market cap: 3611425792 (Mid Cap ($2B-$10B))
P/E ratio: 0.13510690384179505
Debt to equity: 0.12960000000000002
Free cash flow (dilution adjusted): 663632.3823823824
Operating income: 2075925.9259259258
Net income: 1087718.9689689688
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 3672.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2596380160 (Mid Cap ($2B-$10B))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4187.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 105550438400 (Large Cap ($10B-$200B))
P/E ratio: 0.09371113916197878
Debt to equity: 0.0192
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 444A.T (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 538764992 (Small Cap ($300M-$2B))
P/E ratio: 2.004364878086181
Debt to equity: 0.5025
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 444A.T (annual, report date 2025-12-31)
Altman Z-score: 3.8680101788364025 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.695046708959016%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.743691091517176%
Free cash flow margin: 5.007973828645596%
Revenue growth: 6.874906145554793%
Rule of 40 score: 11.882879974200389
Market cap: 538764992 (Small Cap ($300M-$2B))
P/E ratio: 2.004364878086181
Debt to equity: 0.5025
Free cash flow (dilution adjusted): 782002.4295121796
Operating income: 621277.4119301835
Net income: 543258.1037018093
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 6073.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14727796736 (Large Cap ($10B-$200B))
P/E ratio: 0.38632757457697503
Debt to equity: 0.2455
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6086.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 19278702592 (Large Cap ($10B-$200B))
P/E ratio: 0.10114798654444426
Debt to equity: 0.0407
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6110.HK (quarterly, report date 2026-02-28)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8061588480 (Mid Cap ($2B-$10B))
P/E ratio: 1.6783887468030692
Debt to equity: 0.4047
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7069.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5254043648 (Mid Cap ($2B-$10B))
P/E ratio: 0.03310966071778563
Debt to equity: 0.8789
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7267.T (quarterly, report date 2026-03-31)
Altman Z-score: 0.7371060865856798 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.966879705081742%
Capitalized R&D asset: 5996143423.297649
ROCI (R&D adjusted): -3.2830047916910563%
Rosenberg metric: -2.2334362535278443
Free cash flow margin: 2.3847841914355503%
Revenue growth: 6.607741267495529%
Rule of 40 score: 8.992525458931079
Market cap: 5979003420672 (Mega Cap (>= $200B))
Debt to equity: 1.1365
Free cash flow (dilution adjusted): 868474724.7247247
Operating income: -6292861611.611611
Net income: -5456894394.394394
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for 7267.T (annual, report date 2026-03-31)
Altman Z-score: 1.2721109516551672 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 16574826508.020546
ROCI (R&D adjusted): -0.3996640475456946%
Rosenberg metric: -1.1743535900395676
Free cash flow margin: 1.0906099618243386%
Revenue growth: -5.928456494856844%
Rule of 40 score: -4.837846533032506
Market cap: 5979003420672 (Mega Cap (>= $200B))
Debt to equity: 1.1365
Free cash flow (dilution adjusted): 1487212212.212212
Operating income: -2592254754.7547545
Net income: -2208602352.352352
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 7459.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 588815663104 (Mega Cap (>= $200B))
P/E ratio: 0.0889986001107872
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7615.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2007857664 (Mid Cap ($2B-$10B))
P/E ratio: 0.05998507871167047
Debt to equity: 0.0836
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7615.T (annual, report date 2026-03-31)
Altman Z-score: 1.6420157395871902 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.561950060681846%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.164226410961391%
Free cash flow margin: 13.61232273674306%
Revenue growth: 7.941070575578882%
Rule of 40 score: 21.553393312321944
Market cap: 2007857664 (Mid Cap ($2B-$10B))
P/E ratio: 0.05998507871167047
Debt to equity: 0.0836
Free cash flow (dilution adjusted): 5068512.262262262
Operating income: 1620589.3393393394
Net income: 1385216.4664664664
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 7809.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10569266176 (Large Cap ($10B-$200B))
P/E ratio: 0.055203479503634266
Debt to equity: 0.3519
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7879.T (quarterly, report date 2026-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 9475130368 (Mid Cap ($2B-$10B))
Debt to equity: 0.3518
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8163.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 35883948 (Nano Cap (< $50M))
Debt to equity: 0.053
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8163.HK (annual, report date 2025-12-31)
Altman Z-score: -57.18463966984892 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -56.50700520965051%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -22.561661046088737%
Free cash flow margin: -3.3438947111869366%
Revenue growth: -0.5527691932498403%
Rule of 40 score: -3.896663904436777
Market cap: 35883948 (Nano Cap (< $50M))
Debt to equity: 0.053
Free cash flow (dilution adjusted): -88174.80719794345
Operating income: -877120.8226221079
Net income: -1552827.763496144
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for 8431.HK (quarterly, report date 2025-09-30)
Altman Z-score: 1.0414475448212648 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.05188734369522%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.97957770854967%
Revenue growth: -50.55358087477843%
Rule of 40 score: -50.55358087477843
Market cap: 269682496 (Micro Cap ($50M-$300M))
Debt to equity: 0.24969999999999998
Operating income: -88817.48071979434
Net income: -88560.41131105398
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for 9344.T (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4627914240 (Mid Cap ($2B-$10B))
P/E ratio: 0.19955835261553295
Debt to equity: 0.023399999999999997
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9633.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11096134656 (Large Cap ($10B-$200B))
P/E ratio: 0.08424154030127608
Debt to equity: 0.33520000000000005
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9763.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11782683648 (Large Cap ($10B-$200B))
P/E ratio: 0.06069273585197152
Debt to equity: 0.4991
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9879.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8116834816 (Mid Cap ($2B-$10B))
P/E ratio: 2.0652409900130264
Debt to equity: 0.27940000000000004
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ABDN.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4444239872 (Mid Cap ($2B-$10B))
P/E ratio: 0.1274131274131274
Debt to equity: 0.1386
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ABDN.L (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.444268357105123%
Capitalized R&D asset: 0
Free cash flow margin: 23.26647564469914%
Revenue growth: 23.380411150195318%
Rule of 40 score: 46.646886794894456
Market cap: 4444239872 (Mid Cap ($2B-$10B))
P/E ratio: 0.1274131274131274
Debt to equity: 0.1386
Free cash flow (dilution adjusted): 548648648.6486486
Net income: 539189189.1891892
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for ABO.BR (annual, report date 2025-12-31)
Altman Z-score: 1.6749960155292913 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 29.84193369825943%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.867773836183832%
Free cash flow margin: 7.388445279473932%
Revenue growth: 25.423429261539376%
Rule of 40 score: 32.81187454101331
Market cap: 40795316 (Nano Cap (< $50M))
P/E ratio: 103.92156862745098
Debt to equity: 1.2341
Free cash flow (dilution adjusted): 9252941.176470589
Operating income: 4670588.235294118
Net income: 914117.6470588235
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ABO.BR (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 40795316 (Nano Cap (< $50M))
P/E ratio: 103.92156862745098
Debt to equity: 1.2341
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AESI (quarterly, report date 2026-03-31)
Altman Z-score: 0.8241190172124899 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.3592955582704254%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.7790158417976796%
Free cash flow margin: -7.049020456881652%
Revenue growth: 6.475965200657499%
Rule of 40 score: -0.5730552562241531
Market cap: 1493870848 (Small Cap ($300M-$2B))
Debt to equity: 0.5925
Free cash flow (dilution adjusted): -18721000
Operating income: -35802000
Net income: -47264000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ALORA.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5037494 (Nano Cap (< $50M))
Debt to equity: 1.4877
Long score: 0 | Short score: 2
Recommendation: Neutral